Breast Neoplasms: all 12,820 studies
Page 83 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Hypofractionated PBI After BCS for Low-risk Breast Cancer PatientsCompletedNCT03411174Not applicable
- S 81694 Plus Paclitaxel in Metastatic Breast CancerCompletedNCT03411161Phase 1/2
- SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast CancerCompletedNCT03411070Early Phase 1
- Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast CancerCompletedNCT03409198Phase 2
- Metastatic Breast Carcinoma and Women Sexual Quality of LifeCompletedNCT03408769
- Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast SurgeryActive, not recruitingNCT03408717
- Social Media Listening in Improving Clinical Trial Recruitment in Patients With CancerWithdrawnNCT03408561Not applicable
- Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast CancerCompletedNCT03407768Not applicable
- Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsCompletedNCT03407716Early Phase 1
- Routine Therapy Plus Moxifloxacin in Advanced Breast CancerCompletedNCT03405168Phase 2
- Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.Status unknownNCT03404752Phase 3
- Tissue Resistivity in Breast Cancer PatientsCompletedNCT03402997
- The Resistance and Immune Response to Palbociclib in Breast CancerStatus unknownNCT03401359Not applicable
- Influence of Lifestyle, Inflammatory Biomarkers, and Genetic Factors on Long-term Breast Cancer PrognosisCompletedNCT03401034
- Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")WithdrawnNCT03400254Phase 1/2
- Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast CancerActive, not recruitingNCT03400215Not applicable
- Effect of Health Education on Female Teachers' Knowledge and Practices Regarding Early Breast Cancer Detection and Screening in the Jazan Area: A Quasi-Experimental StudyCompletedNCT03398057Not applicable
- Neoadjuvant Endocrine Therapy in Breast CancerCompletedNCT03397537Phase 2
- Pre-operative Immunotherapy Combination Strategies in Breast CancerCompletedNCT03395899Phase 2
- Effects of Green Coffee Extract Supplementation on Adropin, Irisin, Vaspine,Systemic Inflammation and Oxidative Stress in Breast Cancer SurvivorsStatus unknownNCT03395561Not applicable
- Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast CancerStatus unknownNCT03395327
- Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer PatientsCompletedNCT03394742Not applicable
- Effects of Green Coffee Extract Supplementation on Leptin, Ghrelin, Adiponectin,Anthropometric Measurements, Lipid Profile in Breast Cancer SurvivorsStatus unknownNCT03394690Not applicable
- A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBCCompletedNCT03394287Phase 2
- Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer PatientsActive, not recruitingNCT03393845Phase 2
- Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor BiopsyTerminatedNCT03393741
- Evaluation of Gadolinium Deposits in Healthy Women Participating in a High Risk Screening Program for Early Breast Cancer DetectionStatus unknownNCT03393442Not applicable
- Bioelectrical Impedance Utilization and Dietary Intake Relation in the Breast Cancer Related LymphedemaCompletedNCT03391206
- Prognostic and Predictive Factors for Small Breast TumorsCompletedNCT03390608
- Upper Limb Function After Breast Cancer Surgery: the Role of Post-operative Physical Therapy InterventionCompletedNCT03389204Not applicable
- HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast CancerCompletedNCT03387553Early Phase 1
- AKY15-HK-301_NEPA StudyActive, not recruitingNCT03386617Phase 2
- SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast CancerTerminatedNCT03386162Phase 2
- KVUS at Neoadjuvant CTx of Breast CancerStatus unknownNCT03385200Phase 3
- Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer PatientsCompletedNCT03385031
- Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer SurvivorsCompletedNCT03384992Not applicable
- Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast CancerActive, not recruitingNCT03384914Phase 2
- Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated ArthralgiasWithdrawnNCT03384095Phase 2
- Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast CancerActive, not recruitingNCT03383835Not applicable
- Hemostatic Profiles of Endocrine Therapies for Breast CancerCompletedNCT03381963
- Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients.CompletedNCT03381417Phase 3
- Sentinel Lymph Node Biopsy in Clinically Node-negative Early Breast Cancer Patients After Neoadjuvant ChemotherapyStatus unknownNCT03381092
- Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast CancerActive, not recruitingNCT03379428Phase 1/2
- Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast CancerCompletedNCT03377387Phase 1/2
- Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast CancerWithdrawnNCT03377101Phase 2
- Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D MammographyActive, not recruitingNCT03377036Not applicable
- Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer PatientsCompletedNCT03376503Phase 1
- The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation ExposureCompletedNCT03375892Not applicable
- Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast CancerCompletedNCT03375827Not applicable
- Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment.CompletedNCT03375801Not applicable
- Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast CancerStatus unknownNCT03373708Phase 2/3
- Warm Acupuncture for Breast Cancer Related LymphedemaCompletedNCT03373474Not applicable
- Development Of A Blood Test To Improve The Performance Of Breast Cancer ScreeningCompletedNCT03372902
- Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast CancerActive, not recruitingNCT03368729Phase 1/2
- A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single AgentTerminatedNCT03367689Phase 2
- 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)TerminatedNCT03367676Phase 2
- Study of Metabolites Markers in Adjuvant Breast CancerCompletedNCT03367208
- Pathological Fracture in Potentially Unstable Spinal Metastases of Breast CancerStatus unknownNCT03365973
- Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)CompletedNCT03365895Not applicable
- PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast CancerActive, not recruitingNCT03362060Phase 1
- Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBCTerminatedNCT03361800Early Phase 1
- Molecular Evaluation in Metastatic Breast CancerStatus unknownNCT03358589Not applicable
- Engineering Gut Microbiome to Target Breast CancerCompletedNCT03358511Not applicable
- Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast CancerCompletedNCT03358017Phase 2
- the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line TreatmentTerminatedNCT03358004Phase 2
- The Distress-barometer: Face-to-face Interviews or Written Self-report Questionnaires?CompletedNCT03357744
- Circulating Tumor DNA After Neoadjuvant ChemotherapyCompletedNCT03357120Not applicable
- Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.CompletedNCT03356860Phase 1/2
- A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).CompletedNCT03355157Phase 4
- Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain ControlActive, not recruitingNCT03351348Phase 3
- Improving Decision Role Concordance in Newly Diagnosed Breast Cancer PatientsCompletedNCT03350854Not applicable
- Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant ChemotherapyStatus unknownNCT03349177Phase 2/3
- Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer PatientsCompletedNCT03348696Phase 4
- Safety Study of 3D Printing Personalized Biodegradable Implant for Breast ReconstructionCompletedNCT03348293Phase 1
- Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast CancerStatus unknownNCT03348098Phase 2
- 68Ga-NOTA-RM26 PET/CT in Breast Tumor PatientsStatus unknownNCT03347864Early Phase 1
- Olaparib In Metastatic Breast CancerActive, not recruitingNCT03344965Phase 2
- Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) AssayStatus unknownNCT03343691
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer PatientsCompletedNCT03343145Phase 3
- Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer PatientsTerminatedNCT03342417Phase 2
- Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam ScanningWithdrawnNCT03340402Not applicable
- Remifemin Preventing the Climacteric Symptoms in Breast CancerCompletedNCT03339882Phase 2
- Neurovascular Changes Induced by ChemotherapyCompletedNCT03339804Not applicable
- Breast Cancer Recurrence Risk CounselingCompletedNCT03339518Not applicable
- Improving Emotion Regulation at the End of Breast Cancer TreatmentCompletedNCT03336827Not applicable
- Mat Pilates in Women With Breast Cancer During Adjuvant RadiotherapyCompletedNCT03333993Not applicable
- Axillary Reverse Mapping (ARM) in Breast Cancer Surgery to Prevent Lymphedema. (ARMtrial)Status unknownNCT03333226Not applicable
- Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life OutcomesActive, not recruitingNCT03333122
- A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast CancerActive, not recruitingNCT03332797Phase 1
- Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic SurgeryCompletedNCT03330717Not applicable
- Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer PatientsCompletedNCT03328884Phase 2
- Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer SurvivorsCompletedNCT03328169Not applicable
- Combination Study of SV-BR-1-GM With RetifanlimabCompletedNCT03328026Phase 1/2
- Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCTerminatedNCT03326674Phase 3
- Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWithdrawnNCT03326258Phase 1/2
- Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast CancerCompletedNCT03326102Phase 2
- Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast CancerActive, not recruitingNCT03324932Phase 3
- Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast CancerActive, not recruitingNCT03324425Phase 2
- Phase II Trial of Disulfiram With Copper in Metastatic Breast CancerCompletedNCT03323346Phase 2
- HR+/HER2- Advanced Breast Cancer and Endocrine ResistanceTerminatedNCT03322215Phase 2